$213.1M
11-50
MBX Biosciences develops groundbreaking therapies for rare endocrine conditions. Their preclinical-stage biotech solutions aim to revolutionize treatment options for those with these often overlooked diseases.
City Rank
Share
Loading...
In Carmel-by-the-Sea
out of startups
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
City Rank
Share
1st
In Carmel-by-the-Sea
out of 4 startups
National Rank
Share
882nd
In United States
out of 8869 startups
Regional Rank
Share
917th
In North America
out of 9666 startups
City Rank
Share
1st
In Carmel-by-the-Sea
out of 2 startups
National Rank
Share
301st
In United States
out of 3470 startups
Regional Rank
Share
311th
In North America
out of 3719 startups
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...